- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | After setback, Rhythm gets good news on Imcivree from FDA | ||
| Fr | Novartis snaps up PI3Ka breast cancer drug in $3bn deal | ||
| Fr | Appeal finds NICE must reconsider Alzheimer's drugs | ||
| Fr | Kidney biotech R1's $78m debut, and other biofinancings | ||
| Do | FDA approves higher Wegovy dose via 4th priority voucher | ||
| Do | Lilly's triple agonist retatrutide passes diabetes test | ||
| Do | Precision psychiatry push starts in Europe | ||
| Do | Generic semaglutide in India, and other weight-loss news | ||
| Do | Alfasigma claims early FDA nod for ex-GSK liver drug | ||
| Do | FDA publishes advice on animal testing alternatives | ||
| Mi | Basecamp lifts veil on Trillion Gene Atlas genomics push | ||
| Mi | J&J gets FDA okay for psoriasis drug icotrokinra | ||
| Mi | First MHRA/NICE aligned guidance due in June | ||
| Mi | Hope rises for vaccine against hookworm parasite | ||
| Mi | US court says pharma giants must face False Claims suit | ||
| Di | Meningitis outbreak in UK prompts call to widen vaccination | ||
| Di | Alto raises $120m for resistant depression programme | ||
| Di | BioMarin halts Voxzogo trials due to safety signal | ||
| Di | Roche accelerates AI adoption with NVIDIA deal | ||
| Di | US judge rules Kennedy's vaccine changes 'unlawful' | ||
| Mo | AZ piles pressure on MSD et al in gastric cancer | ||
| Mo | Denying prostate cancer screening 'no longer rational' | ||
| Mo | Data builds behind Bayer's Kerendia in kidney disease | ||
| Mo | J&J says Inlexzo follow-up 'promising' in bladder cancer | ||
| Mo | GSK's RSV shot cleared in US for all adults |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.